PropertyValue
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/ns/prov#value
  • Immun. 58, 2367-2374).In another embodiment, the present invention relates to a pharmaceutical composition comprising the above described polysaccharide-protein conjugate in an amount sufficient to prevent systemic infections including meningitis, caused by group B orgroup C Neisseria meningitidis, Escherichia coli K1, Moraxella nonliquefaciens, Pasteurella haemolytica, or other microorganisms con
http://www.w3.org/ns/prov#wasQuotedFrom
  • patentgenius.com